Cytochrome P450 variations in different ethnic populations

J McGraw, D Waller - Expert opinion on drug metabolism & …, 2012 - Taylor & Francis
Introduction: Variability of drug response is an important consideration in clinical medicine. A
major determinant of drug response variability is hepatic cytochrome P450 oxidase …

Efavirenz in the therapy of HIV infection

NY Rakhmanina, JN Van den Anker - Expert opinion on drug …, 2010 - Taylor & Francis
Importance of the field: The use of the first generation non-nucleoside reverse transcriptase
inhibitor efavirenz (EFV) as a component of first-line antiretroviral therapy has been …

Adverse neuropsychiatric events and recreational use of efavirenz and other HIV-1 antiretroviral drugs

DA Dalwadi, L Ozuna, BH Harvey, M Viljoen… - Pharmacological …, 2018 - Elsevier
Efavirenz is a highly effective HIV-1 antiretroviral; however, it is also frequently associated
with neuropsychiatric adverse events (NPAE) that include abnormal dreams, sleep …

Worldwide Variation in Human Drug-Metabolism Enzyme Genes CYP2B6 and UGT2B7: Implications for HIV/AIDS Treatment

J Li, V Menard, RL Benish, RJ Jurevic… - …, 2012 - Taylor & Francis
Aim: Hepatic enzymes, CYP2B6 and UGT2B7 play a major role in the metabolism of the
widely used antiretroviral drugs efavirenz, nevirapine and zidovudine. In the present study …

PharmGKB summary: very important pharmacogene information for CYP2B6

CF Thorn, JK Lamba, V Lamba, TE Klein… - Pharmacogenetics …, 2010 - journals.lww.com
CYP2B6 is a member of the cytochrome P450 family of important pharmacogenes and
makes up approximately 2–10% of the total hepatic CYP content [1]. CYP2B6 is also …

Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults

S Uttayamakul, S Likanonsakul, W Manosuthi… - AIDS research and …, 2010 - Springer
Abstract Background Cytochrome P450 2B6 (CYP2B6) metabolizes efavirenz and
nevirapine, the major core antiretroviral drugs for HIV in Thailand. Rifampicin, a critical …

Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV‐1 infected Thai adults

C Sukasem, TR Cressey, P Prapaithong… - British journal of …, 2012 - Wiley Online Library
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• Interindividual variability in efavirenz
plasma concentrations is associated with CYP2B6 genetic polymorphisms.• Twenty‐nine …

Population pharmacokinetic-pharmacogenetic study of nevirapine in HIV-infected Cambodian patients

M Chou, J Bertrand, O Segeral, C Verstuyft… - Antimicrobial agents …, 2010 - Am Soc Microbiol
The aims of this ANRS12154 open-label, single-center, multiple-dose pharmacokinetic
study were to characterize nevirapine pharmacokinetics in a Cambodian population of HIV …

Pediatric underdosing of efavirenz: a pharmacokinetic study in Uganda

Q Fillekes, E Natukunda, J Balungi… - JAIDS Journal of …, 2011 - journals.lww.com
Methods Forty-one HIV-infected Ugandan children (3–12 years) on efavirenz+ lamivudine+
abacavir were enrolled in a study of twice-daily to once-daily lamivudine+ abacavir 36 …

Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected Thai children

TR Cressey, L Aurpibul, T Narkbunnam… - JAIDS Journal of …, 2013 - journals.lww.com
2283-2296. 8. Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalence and
incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med. 2005; …